Mohamad El-Zaatari MD, PhD
of University of Michigan moderated the Funderburg Symposium which included Dr. Avery Posey, an investigator from Dr. Carl June's lab, who pioneered CAR-T cell therapy against hematological tumors, at the University of Pennsylvania. One of the major obstacles for this type of therapy against solid organ tumors is the inability of programmed killer T cells to effectively infiltrate into the tissue of solid organs. Dr. El-Zaatari from the University of Michigan has identified a mechanism to enable such killer T cells to potently infiltrate the stomach. Through this DDW panel, a new collaboration among these researchers has been formed to optimize this therapy against stomach cancer.